Skip to main content
OEC
NYSE Life Sciences

Orion Secures FDA Approval for Proprietary Dog Anxiety Drug Tessie®, Zoetis to Lead US Sales

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$7.5
Mkt Cap
$419.532M
52W Low
$4.345
52W High
$12.1
52W Position info
73% above low
Off High info
38% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

OEC sits 73% above its 52-week low of $4.345.

Summary

Orion Animal Health has received US FDA approval for Tessie® (tasipimidine oral solution), a proprietary molecule for treating noise aversion and separation anxiety in dogs. This significant regulatory milestone provides a new potential revenue stream for Orion, especially as it follows the company's recent Q1 2026 report detailing a net loss and a substantial drop in Adjusted EBITDA. The approval, which occurred on May 6, positions Tessie® to be marketed and sold exclusively in the United States by Orion's strategic partner, Zoetis, a major player in animal health. While the product is not anticipated to be available until mid-2027, this approval validates Orion's R&D capabilities and offers a clear future growth driver. Traders will monitor further updates on commercialization plans and sales forecasts.

At the time of this announcement, OEC was trading at $7.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $419.5M. The 52-week trading range was $4.35 to $12.10. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

OEC - Latest Insights

OEC
Nov 04, 2026, 4:40 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.90
Real-time Price: $3.26 info
Change: -$2.64 (-45%) info
Market Cap: $184.264M info
OEC
Nov 04, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $5.87
Real-time Price: $3.26 info
Change: -$2.61 (-44%) info
Market Cap: $184.264M info
OEC
Oct 24, 2026, 2:35 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.45
Real-time Price: $3.26 info
Change: -$2.19 (-40%) info
Market Cap: $184.264M info
OEC
Oct 20, 2026, 1:20 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.46
Real-time Price: $3.26 info
Change: -$2.20 (-40%) info
Market Cap: $184.264M info
OEC
Oct 06, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.85
Real-time Price: $3.26 info
Change: -$2.59 (-44%) info
Market Cap: $184.264M info